<DOC>
	<DOCNO>NCT02548403</DOCNO>
	<brief_summary>Optimal bowel preparation essential colonoscopy efficacy safety . Mucosal visualization colonoscopy often limited residual stool , bubble , bile , intraluminal fluid , debris , increase risk miss flat adenomas small lesions.Therefore , intestinal preparation necessary remove residual material prior endoscopy . A combined agent , low-dose PEG ascorbic acid ( PEG-Asc ) , one low-volume solution commonly use Korea ( Coolprep® ; TaeJoon Pharmaceuticals , Seoul , Korea ) . However , practitioner note increased incidence bubble formation preparation method . To investigator knowledge , previous study assess colon preparation patient administer simethicone . The purpose study compare quality bowel preparation compliance PEG-Asc PEG-Asc simethicone . The effectiveness add simethicone antifoaming agent improve bowel cleanse colonoscopy evaluate term bowel preparation scale bubble score , compliance patient endoscopists also investigate use questionnaire .</brief_summary>
	<brief_title>Effect Simethicone Bowel Preparation Colonoscopy</brief_title>
	<detailed_description>1 . Study design : endoscopist-blinded , prospective , randomize control trial 2 . Subjects - A single-center , randomize , observer-blinded study perform Korea University Hospital Anam . Outpatients prospectively enrol . Each group patient receive PEG-Asc PEG-Asc simethicone colonoscopy . 3 . Sampling design : Consecutive recruitment consent patient 4 . Variables Predictor 1. group 1 ( PEG-Asc ) receive 1 L solution PEG-Asc 7 p.m even colonoscopy another 1 L solution PEG-Asc 5 hour procedure ; 2. group 2 ( PEG-Asc simethicone ) receive 1 L solution PEG-Asc 7 p.m even colonoscopy another 1 L solution PEG-Asc 5 hour procedure ; Two pack ( 200 mg/10 mL ) simethicone ( 400 mg ) mix last 500 mL additional clear fluid . 5 . Primary Outcome : Quality bowel preparation [ Boston Bowel Preparation Scale , bubble score ] 6 . Secondary Outcome : Patients endoscopists ' compliance [ Tolerability , palatability patient , fatigue score endoscopist ]</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Simethicone</mesh_term>
	<criteria>Male female patient , age between18 80 year undergoing elective outpatient colonoscopy eligible study patient chronic kidney disease , severe heart failure ( New York Heart Association [ NYHA ] class III IV ) uncontrolled hypertension ( systolic pressure ≥170 mm Hg , diastolic pressure ≥100 mm Hg ) severe constipation bowel resection significant gastroparesis , suspect bowel obstruction perforation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Bowel preparation</keyword>
	<keyword>Simethicone</keyword>
	<keyword>Polyethylene glycol ascorbic acid</keyword>
</DOC>